Impact of skeletal muscle volume on patients with BCLC stage‐B hepatocellular carcinoma undergoing sorafenib therapy
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Medicine"
DOI: 10.1002/cam4.5810
Abstract: Skeletal muscle volume has been reported to be an important factor that determines overall survival (OS) and post‐progression survival (PPS) in patients with hepatocellular carcinoma (HCC). However, the impact of skeletal muscle volume on HCC… read more here.
Keywords: bclc stage; skeletal muscle; muscle volume;
Prognostic Factors for Survival After Transarterial Chemoembolization Combined with Sorafenib in the Treatment of BCLC Stage B and C Hepatocellular Carcinomas.
Sign Up to like & getrecommendations! Published in 2018 at "Academic radiology"
DOI: 10.1016/j.acra.2017.10.018
Abstract: RATIONALE AND OBJECTIVE The objective of this study was to analyze prognostic factors for survival after transarterial chemoembolization (TACE) combined with sorafenib for hepatocellular carcinoma (HCC) of Barcelona Clinic Liver Cancer (BCLC) stages B and… read more here.
Keywords: combined sorafenib; sorafenib treatment; prognostic factors; bclc stage ... See more keywords
Impact of time to surgery in the outcome of patients with liver resection for BCLC 0-A stage hepatocellular carcinoma.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of hepatology"
DOI: 10.1016/j.jhep.2017.09.017
Abstract: BACKGROUND & AIMS The Barcelona Clinic Liver Cancer (BCLC) guidelines recommend resection for very early and early single hepatocellular carcinoma (HCC) patients. It is not known whether a delay in resection from the time of… read more here.
Keywords: surgery; recurrence; impact; time ... See more keywords
Surgical management of hepatocellular carcinoma within and beyond BCLC indications in a middle volume center.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of visceral surgery"
DOI: 10.1016/j.jviscsurg.2017.12.001
Abstract: AIM OF THE STUDY Current criteria for hepatic resection in patients with hepatocellular carcinoma (HCC) according to Barcellona Clinic Liver Cancer (BCLC) classification is debated. Actually, patients with multinodular or large HCC>5cm are excluded from… read more here.
Keywords: hepatocellular carcinoma; volume center; bclc stage; stage ... See more keywords
Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2017 at "Scientific Reports"
DOI: 10.1038/srep41624
Abstract: Combinations of transarterial chemoembolization (TACE) and radical therapies (pretransplantation, resection and radiofrequency ablation) for hepatocellular carcinoma (HCC) have been reported as controversial issues in recent years. A consecutive sample of 1560 patients with Barcelona Clinic… read more here.
Keywords: hepatocellular carcinoma; tace; radical therapies; transarterial chemoembolization ... See more keywords
A Prospective Study Using Propensity Score Matching to Compare Long-term Survival Outcomes After Robotic-assisted, Laparoscopic, or Open Liver Resection for Patients With BCLC Stage 0-A Hepatocellular Carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Surgery"
DOI: 10.1097/sla.0000000000005380
Abstract: Objective: To compare the short- and long-term outcomes of robot-assisted (RALR), laparoscopic (LLR), or open liver resection (OLR) in the treatment of Barcelona Clinic Liver Cancer (BCLC) stage 0-A hepatocellular carcinoma (HCC). Summary Background Data:… read more here.
Keywords: long term; liver; survival; term ... See more keywords
A new ALBI‐based model to predict survival after transarterial chemoembolization for BCLC stage B hepatocellular carcinoma
Sign Up to like & getrecommendations! Published in 2019 at "Liver International"
DOI: 10.1111/liv.14194
Abstract: Transarterial chemoembolization (TACE) is a standard treatment for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma (HCC), but the outcome varied. This study aimed to develop a model to predict the outcome of TACE… read more here.
Keywords: hepatocellular carcinoma; model predict; transarterial chemoembolization; bclc stage ... See more keywords
Changing TACTICS in intermediate HCC: TACE plus sorafenib
Sign Up to like & getrecommendations! Published in 2020 at "Gut"
DOI: 10.1136/gutjnl-2020-320692
Abstract: Hepatocellular carcinoma (HCC) represents a serious health problem, mainly due to the high cancer-related mortality. Transarterial chemoembolisation (TACE) is currently used as the first-line treatment for intermediate-stage HCC (Barcelona Clinic Liver Cancer (BCLC) stage B),… read more here.
Keywords: tace; plus sorafenib; tace plus; bclc stage ... See more keywords
A multi-institutional predicting nomogram for BCLC stage C hepatocellular carcinoma after stereotactic body radiotherapy.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.4_suppl.353
Abstract: 353Background: The study aimed to develop a nomogram to predict overall survival (OS) among hepatocellular carcinoma (HCC) patients with BCLC stage C after stereotactic body radiotherapy (SBRT). Methods: Clinical data from the multicenter study consisted… read more here.
Keywords: hepatocellular carcinoma; body radiotherapy; stereotactic body; bclc stage ... See more keywords
TACE combined with apatinib for the treatment of BCLC stage C of hepatocellular carcinoma: A restrospective controlled study.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.4_suppl.445
Abstract: 445Background: To access the safety and effcacy of transarterial chemoembolization (TACE) combined with apatinib (TACE-apatinib) for the treatment of Barcelona Clinic Liver Cancer (BCLC) stage C of... read more here.
Keywords: tace; combined apatinib; tace combined; apatinib treatment ... See more keywords
Predictors of poor outcome for transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC).
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.4100
Abstract: 4100 Background: The use of TACE in select patients with BCLC stage B HCC has been shown to improve survival. Despite this, it remains unclear which patients will benefit from repeated TACE versus switching to… read more here.
Keywords: bclc stage; hcc; tace; tace treatments ... See more keywords